RCS - Oxford Nanopore Tech - Oxford Nanopore to present at upcoming conferences

Oxford Nanopore TechnologiesAnnouncement

05/09/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240905:nRSE0386Da&default-theme=true

RNS Number : 0386D  Oxford Nanopore Technologies plc  05 September 2024

5 September 2024

Oxford Nanopore Technologies plc

Oxford Nanopore to present at upcoming investor conferences

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company
delivering a new generation of nanopore-based molecular sensing technology,
will be presenting at the following investor conferences in September.

 

·      Goldman Sachs 21st Annual Medtech and Healthcare Services
Conference on Thursday, 5 September at 9:00am BST in London, UK

·      BofA Securities Global Healthcare Conference 2024 on Wednesday,
18 September at 1:20pm BST in London, UK

·      Bernstein's 21st Pan European Annual Strategic Decisions
Conference on Wednesday, 25 September at 9:00am BST in London, UK

 

Live webcasts of the events can be accessed at the company's investor
relations page at: https://nanoporetech.com/about/investors/reports
(https://nanoporetech.com/about/investors/reports) . Webcast replays will be
available for at least 30 days following the events via the same link.

 

-ENDS-

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:         ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:              media@nanoporetech.com
(mailto:media@nanoporetech.com)

 

Teneo (communications adviser to the Company)

Tom Murray, Olivia Peters

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com
(mailto:OxfordNanoporeTechnologies@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries, to
understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer.  Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRALAMITMTMMMII